Understanding the role of CD4+CD25high (so-called regulatory) T cells in idiopathic pulmonary arterial hypertension

Respiration

Volumn 75, Issue 3, 2008, Pages 253-256

  Perros, Frédéric ^a,b   Cohen Kaminsky, Sylvia ^a   Humbert, Marc ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; EDITORIAL; INFLAMMATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REGULATORY T LYMPHOCYTE;

CELL PROLIFERATION; DNA METHYLATION; ENDOTHELIUM, VASCULAR; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; T-LYMPHOCYTES, REGULATORY;

EID: 41349122422     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000114655     Document Type: Editorial

References (36)

1. Dorfmuller P, Perros F, Balabanian K, Humbert M: Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-363.
2. Jouve P, Humbert M, Chauveheid MP, Jais X, Papo T: POEMS syndrome-related pulmonary hypertension is steroid-responsive. Respir Med 2007;101:353-355.
3. Montani D, Achouh L, Marcelin AG, Viard JP, Hermine O, Canioni D, Sitbon O, Simonneau G, Humbert M: Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease. Eur Respir J 2005;26:969-972.
4. Sanchez O, Sitbon O, Jais X, Simonneau G, Humbert M: Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 2006;130:182-189.
5. Jais X, Launay D, Yaic A, Le Pavec J, Tcherakian C, Sitbon O, Simonneau G, Humbert M: Management of lupus and mixed connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum, in press.
6. Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M: Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007;86:299-315.
7. Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia-de-la-Peña-Lefebvre P, Brunet S, Servettaz A, Weill B, Simonneau G, Guillevin L, Boissier MC, Mouthon L: Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005;60:765-772.
8. Tamby MC, Humbert M, Guilpain P, Servettaz A, Dupin N, Christner JJ, Simonneau G, Fermanian J, Weill B, Guillevin L, Mouthon L: Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir J 2006;28:799-807.
9. Mouthon L, Guillevin L, Humbert M: Pulmonary arterial hypertension: an autoimmune disease? Eur Respir J 2005;26:986-988.
10. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF: Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 2005;26:1110-1118.
11. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D: Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995;151:1628-1631.
12. Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, Capron F: Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007;38:893-902.
13. Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S: Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2007;176:1041-1047.
14. Dorfmuller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G, Capron F, Coulomb-Lhermine A, Marfaing-Koka A, Simonneau G, Emilie D, Humbert M: Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165:534-539.
15. Balabanian K, Foussat A, Dorfmuller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol AC, Simonneau G, Emilie D, Humbert M: CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165:1419-1425.
16. Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Mussot S, Mazmanian M, Herve P, Emilie D, Simonneau G, Humbert M: Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 2007;29:462-468.
17. Ulrich S, Nicolls MR, Taraseviciene L, Speich R, Voelkel N: Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 2008;75:272-280.
18. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY: Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006;103:6659-6664.
19. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE: Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007;37:129-138.
20. Ziegler SF: FOXP3: not just for regulatory T cells anymore. Eur J Immunol 2007;37:21-23.
21. Tran DQ, Ramsey H, Shevach EM: Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007;110:2983-2990.
22. + conventional T cells. Eur J Immunol 2007;37:2378-2389.
23. Raychaudhuri B, Bonfield TL, Malur A, Hague K, Kavuru MS, Arroliga AC, Thomassen MJ: Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clin Immunol 2002;104:191-198.
24. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001;163:316-321.
25. + Tregs. J Clin Invest 2006;116:2434-2441.
26. high regulatory T cells. Blood 2004;103:2410-2416.
27. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Kambouchner M, Valeyre D, Chapelon-Abric C, Debre P, Piette JC, Gorochov G: The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006;203:359-370.
28. Leipe J, Skapenko A, Lipsky PE, Schulze-Koops H: Regulatory T cells in rheumatoid arthritis. Arthritis Res Ther 2005;7:93.
29. Balashov KE, Khoury SJ, Hafler DA, Weiner HL: Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. J Clin Invest 1995;95:2711-2719.
30. Zhou J, Carr RI, Liwski RS, Stadnyk AW, Lee TD: Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J Immunol 2001;167:107-113.
31. + regulatory T cells in vivo in humans. Blood 2002;100:174-177.
32. - T cells in an autoimmune disease model. J Clin Invest 2003;112:1037-1048.
33. Liu J, Liu Z, Witkowski P, Vlad G, Manavalan JS, Scotto L, Kim-Schulze S, Cortesini R, Hardy MA, Suciu-Foca N: Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 2004;13:239-247.
34. Xystrakis E, Dejean AS, Bernard I, Druet P, Liblau R, Gonzalez-Dunia D, Saoudi A: Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 2004;104:3294-3301.
35. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC: TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005;115:2904-2913.
36. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza F, Lederman S, Colonna M, Cortesini R, Dalla-Favera R, Suciu-Foca N: Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3:237-243.